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Gene expressionial changes in the gene expression pattern of human myeloid leukaemia HL-60
cells during their neutrophil differentiation induced by dimethyl sulfoxide (DMSO) that account for the
acquisition of mature neutrophil phenotypic hallmarks. Following 1-day DMSO treatment, HL-60 cells were
committed to neutrophil differentiation with loss of their proliferative capacity, and gene expression changes
were mostly related to transcription and cell cycle, including up-regulation of inhibitor of DNA binding (Id)
genes and down-regulation of cyclins, CDC kinases and MCM proteins. After 3–4-day DMSO treatment, zinc
ﬁnger proteins 266 and 51 (BCL-6) were dramatically up-regulated, and additional gene expression changes,
involving functional and signalling proteins as well as genes involved in RNA processing, apoptosis, and
protein degradation, correlated with acquisition of the mature neutrophil phenotype. Our data deﬁne
changes in the gene expression pattern of a rather restricted number of genes during the differentiation
process that seem to regulate neutrophil maturation, providing a molecular basis for the acquisition of
neutrophil phenotype. Peripheral blood mature neutrophils showed a qualitatively similar expression proﬁle
for these selected genes. These results show changes in gene expression during the transformation of a
proliferating leukaemic cell into an end apoptotic-prone cell, which might be of importance to get a
molecular insight for the use of differentiation therapy in leukaemia.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The genetic lesions of leukaemia result in a blockage of cell
differentiation that allows leukaemic cells to continue to proliferate
and prevents the terminal differentiation and apoptosis of normal
leukocytes. Differentiation therapy is an anti-neoplastic strategy that
tries to overcome the maturation arrest of leukaemic cells and it has
received increasing attention due to the remarkable activity of all-
trans retinoic acid as a differentiation-inducing drug in patients with
acute promyelocytic leukaemia (APL) (Huang et al., 1988; Tallman,
1996; Chen et al., 2007). Myeloid leukaemia cells established from
patients with either acute myeloid leukaemia (AML) or the blastic
phase of chronic myeloid leukaemia (CML) are arrested at differentAAT/enhancer binding protein;
rotein 6; Id, inhibitor of DNA
horbol-13-acetate.
34 923 294795.
rights reserved.stages of cell maturation, and have been widely used as models of
myeloid differentiation. The human acute myeloid leukaemia HL-60
cell line was derived from a patient initially considered to have acute
promyelocytic leukaemia (APL) (Collins et al., 1977), but showed
atypical clinical features, including lack of the t(15:17) chromosomal
translocation that represents a cytogenetic hallmark for APL. Further
studies reclassiﬁed the leukaemia from which the HL-60 cells were
derived as an AML with maturation (Dalton et al., 1988). HL-60 cells
can be induced to differentiate in vitro towards the polymorpho-
nuclear neutrophil lineage following dimethyl sulfoxide (DMSO)
treatment (Collins, 1987; Mollinedo et al., 1998). Neutrophil matura-
tion of HL-60 cells is somewhat defective, shown by failure in forming
speciﬁc/secondary granules, and by qualitative and quantitative
differences in gene expression between neutrophil-differentiated
HL-60 cells and peripheral blood neutrophils (Collins, 1987; Mollinedo
et al., 1992; Itoh et al., 1998). However, despite these drawbacks,
differentiated HL-60 cells share many functional features with
peripheral blood mature neutrophils, and therefore HL-60 cells are
an invaluable tool in different areas of neutrophil biology, including
17F. Mollinedo et al. / Gene 419 (2008) 16–26neutrophil differentiation and function (Gahmberg et al., 1979;
Newburger et al., 1979; Collins, 1987; Collado-Escobar and Mollinedo,
1994; Mollinedo et al., 1998; Hauert et al., 2002).
A number of studies have analysed themodulation and role of one or
few genes at a time in the neutrophil differentiation process. In this
regard, transcription factor C/EBP (CCAAT/enhancer bindingprotein) has
been shown to regulate neutrophil maturation (Chih et al., 1997;
Lekstrom-Himes et al., 1999; Lekstrom-Himes, 2001). However, our
understanding of the global mechanism occurring during neutrophil
differentiation is still sketchy, and the precise mechanism of neutrophil
differentiation aswell as themajor underlying gene expression changes
remains uncertain. The complexity and diversity of the processes
involved, and the existence of mechanisms still unknown, make it
difﬁcult to identify critical factors in neutrophil differentiation and lead
to the need to use a high-throughput technology able to evaluate global
geneexpressionpatterns. Previous cDNAmicroarrayanalyses during12-
O-tetradecanoylphorbol-13-acetate (TPA)-induced differentiation
towards monocytic lineage (Seo et al., 2000; Zheng et al., 2002) and
all-trans retinoic acid-induced differentiation towards neutrophils (Lee
et al., 2002) of HL-60 cells, as well as an oligonucleotide microarray
analysis during monocytic TPA-induced HL-60 differentiation (Tamayo
et al., 1999) have highlighted the complexity of the differentiation
process. However, microarray studies using DMSO-induced HL-60
differentiation and analyses correlating gene expression patterns with
acquisition of neutrophil phenotypic hallmarks have not yet been
performed. Treatment of HL-60 cells with DMSO leads to a gradual
neutrophil differentiation process that entails longer incubation times
than retinoic acid-induced differentiation (Mollinedo et al., 1998), and
thereby allows a more precise differential analysis of gene expression
patterns coupled to the acquisition of distinct neutrophil features at
different neutrophil differentiation stages. Here, we have analysed the
differential gene expression patterns during DMSO-induced neutrophil
differentiation of HL-60 cells using oligonucleotidemicroarrays, andwe
have coupled changes in gene expression proﬁles with the distinct
phenotypic characteristics acquired by neutrophil differentiating HL-60
cells.
2. Materials and methods
2.1. Cell culture and neutrophil isolation
HL-60 cells were cultured in RPMI-1640 supplemented with 10%
(v/v) heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine,
100 units/ml penicillin, and 100 μg/ml streptomycin at 37 °C in a
humidiﬁed atmosphere of 5% CO2 and 95% air. HL-60 cells were
induced to differentiate towards the neutrophil lineage by incubation
with 1.3% (v/v) DMSO (Mollinedo et al., 1998). Neutrophils were
obtained from fresh human peripheral blood by dextran sedimenta-
tion and Ficoll-Hypaque centrifugation, followed by hypotonic lysis of
residual erythrocytes as previously described (Santos-Beneit and
Mollinedo, 2000). The ﬁnal cell preparation contained more than 99%
neutrophils, as assessed by May–Grünwald–Giemsa staining.
2.2. Immunoﬂuorescence ﬂow cytometry
Cell surface expression of CD11b antigen was analysed by immuno-
ﬂuorescence ﬂow cytometry as previously described (Mollinedo et al.,
1992), using the anti-CD11b Bear-1monoclonal antibody and the P3X63
myeloma culture supernatant, as a negative control (kindly provided by
Dr. F. Sánchez-Madrid, Hospital de la Princesa, Madrid, Spain).
2.3. Proliferation assay
Cells (105/ml) were incubated in 96-well plates with 250 μl of
culture medium in the absence and in the presence of DMSO, and
pulsed with 0.5 μCi of [3H]thymidine/ml for 12 h, before harvesting inglass-ﬁbre ﬁlters, and [3H]thymidine incorporationwas measured in a
liquid-scintillation counter (Collado-Escobar and Mollinedo, 1994).
Results were expressed as percentage of proliferation with respect to
control values for untreated cells (100%).
2.4. Secretion assay
Cells (106/ml) were preincubated with 5 μg/ml cytochalasin B in
HEPES/glucose buffer (150 mMNaCl, 10 mMHEPES, 5 mM KCl, 1.2 mM
MgCl2, 1.3 mM CaCl2, 5.5 mM glucose, pH 7.5) for 5 min at 37 °C,
transferred to tubes containing 20 ng/ml TPA and incubated for a
further 10 min at 37 °C. Then, the tubes were placed on ice and
centrifuged at 300 g for 8 min. Supernatants were saved and assayed
for N-acetyl-β-glucosaminidase activity, as previously described
(Mollinedo, 1986; Collado-Escobar and Mollinedo, 1994). Results
were expressed as percentage of enzyme release with respect to
total enzyme content, and corrected for enzyme release from
unstimulated cells.
2.5. Apoptosis assay
The induction of apoptosis wasmonitored as the appearance of the
sub-G1 peak in cell cycle analysis (Gajate et al., 2000), using a Becton
Dickinson FACSCalibur ﬂow cytometer (San Jose, CA). Quantitation of
apoptotic cells was calculated as the percentage of cells in the sub-G1
region (hypodiploidy) in cell cycle analysis.
2.6. Respiratory burst activity
The generation of superoxide anionwasmeasuredby the superoxide
dismutase-inhibitable reduction of ferricytochrome c in a discontinuous
assay upon TPA stimulation (Mollinedo et al., 1991a). Superoxide anion
generation is expressed as nmol of cytochrome c reduced per 106 cells
per 10 min.
2.7. Affymetrix microarray analysis
We analysed RNA samples prepared from 3 independent experi-
ments for each experimental condition, namely resting peripheral
blood human neutrophils, untreated HL-60 cells as well as HL-60 cells
treated with 1.3% (v/v) DMSO for 1, 2, 3, and 4 days. Total RNA was
isolated using a RNeasy kit (Qiagen, Valencia, CA). RNA integrity was
assessed with an AGILENT 2100 Bioanalyzer (Agilent Technologies,
Waldbronn, Germany) using a RNA Nano LabChip (Agilent Technol-
ogies). In this way, we found that our RNA preparations were free of
DNA contamination. Double-stranded cDNA was synthesized from
15 μg of total RNA by means of the SuperScript™ double-stranded
cDNA synthesis kit (Invitrogen, San Diego, CA) with oligo(dT)24 primer
containing T7 RNA polymerase promoter. In vitro transcription was
carried out using the Bioarray High Yield RNA Transcript Labelling kit
(Enzo Diagnostics, Farmingdale, NY) with biotinylated cytidine
triphosphate and uridine triphosphate. The biotin-labelled comple-
mentary RNA (cRNA) was puriﬁed with an RNeasy column and
fragmented at 94 °C for 35 min in fragmentation buffer (40 mM Tris
acetate, pH 8.1, 100 mM potassium acetate, 30 mM magnesium
acetate). Integrity of cDNA, cRNA, and fragmented cRNA was assessed
by electrophoresis of the samples on 1% agarose gels.
Microarray RNA analysis was performed according to the manu-
facturer's protocol using Human Genome U95Av2 GeneChip oligonu-
cleotide arrays (Affymetrix, Santa Clara, CA), that contain 12,625 sets
of oligonucleotide probes, representing about 12,000 full-length
genes. Additional microarray analyses were conducted with Human
Genome U133A arrays (Affymetrix, Santa Clara, CA), that containmore
than 22,000 probe sets, representing 18,400 transcripts, including
14,500 well-characterized human genes. Chips were stained and
washed using an Affymetrix ﬂuids station and following the
18 F. Mollinedo et al. / Gene 419 (2008) 16–26manufacturer's protocol. Chips were scanned with the HP Agilent
GeneArray Scanner and values were normalized and analysed with the
AffymetrixMicroarrays Suite 5.0 (MAS5.0) software (U95Av2 chips) or the
dChip1.3 software (U133A chips). Using MAS5.0 software, arrays were
scaled to an average intensity of 100 using 1 as normalization factor and
analysed independently, using the untreated control samples as baseline.
We compared average “signal” values (representative values of absolute
intensity) from samples treatedwith 1.3% (v/v)DMSO for 1, 2, 3 and 4 days
in triplicates using as baseline the average value of day 0 (untreated), and
obtained a log number (base 2) called “signal log ratio” (SLR) algorithm,
which is a quantitative measure of relative change in transcript
abundance. The SLR algorithm measures the magnitude and direction of
change between transcript levels of the experimental and baseline chips.
The use of logs in the analysis between the probe sets eliminates
difﬁculties caused by one very high data point in the set masking
information from lower valued data points. SLR is related to the fold
change by the following formula:
Fold change ¼ 2SLR for SLRz0
Fold change ¼ −1ð Þ  2−SLR for SLR<0:
Using the Data Mining Tool 3.0 software (Affymetrix), genes with a
“Signal” value higher than 30 were considered up- or down-regulated
if the expressionwas changed at least two-fold (SLR values higher than
1 or lower than −1) from the control. Data with a low signal intensity
(<30) andhigh variability amongexperiments (N15%)were eliminated.
The selected geneswere subjected to cluster analysis according to their
expression levels in the different incubation times using a hierarchical
clustering with average linkage method and uncentred correlation
through Cluster and TreeView software programs (Eisen et al., 1998),
and analysed using the Gene Ontology Mining Tool. When dChip1.3
software was used, a stringent requirement included a gene's
expression level within replicate arrays to be consistent, in terms of
median “standard deviation/mean” ratio of all replicate groups where
this gene is called “present”. Only values with a 0<median (standard
deviation/mean)<0.025 variation within triplicate assays were con-
sidered. This ﬁltering excludes genes that are inherently variable
during sample ampliﬁcation and hybridization stages, asmanifested in
inconsistent expression values between replicate arrays.
2.8. RT-PCR, cDNA cloning and sequencing
Total RNA was prepared from cells using a RNeasy kit and RNA
integrity was assessed as above with an AGILENT 2100 Bioanalyzer
using a RNA Nano LabChip. For the RT reactions, total RNA (10 μg) was
primed with oligo(dT) and reverse-transcribed into cDNA with
30 units of M-MLV reverse transcriptase (Promega, Madison, WI),
according to themanufacturer's instructions, in a ﬁnal volume of 20 μl.
The mixture was incubated at 37 °C for 2 h. The generated cDNA was
used for the semiquantitative RT-PCR analysis to assess mRNA
expression as previously described (Mollinedo et al., 1997; Santos-
Beneit and Mollinedo, 2000), and the β-actin gene was used as an
internal control. A 25-μl PCR mixture contained 1 μl of the RT reaction,
10 pmol of each primer, each dNTP (0.2mM),10mMTris–HCl (pH 8.3),
50 mM KCl, 1.5 mM MgCl2, and 2.5 units of EcoTaq DNA polymerase
derived from Thermus aquaticus. PCR reactions were performed in a
GeneAmp PCR System model 9600 (Perkin Elmer, Norwalk, CT). The
primers used are listed below, where the nucleotide numbers indicate
the primer location in the corresponding sequences of human origin
obtained from the GeneBank/EMBL database:
β-actin (accession number: X00351)
(forward; nt 936–955) 5′-CTGTCTGGCGGCACCACCAT-3′
(reverse; nt 1170–1189) 5′-GCAACTAAGTCATAGTCCGC-3′
A1 (accession number: U27467)(forward; nt 65–86) 5′-AGGCTGGCTCAGGACTCTCTGC-3′
(reverse; nt 544–568) 5′-TTCTGGTCAACAGTATTGCTTCAGG-3′
caspase-1 (accession number: U13700)
(forward; nt 6–25) 5′-CGACAAGGTCCTGAAGGAGA-3′
(reverse; nt 1062–1081) 5′-CATCTGGCTGCTCAAATGAA-3′
caspase-3 (accession number: U26943)
(forward; nt 340–361) 5′-TTTGTTTGTGTGCTTCTGAGCC-3′
(reverse; nt 720–739) 5′-ATTCTGTTGCCACCTTTCGG-3′
VAMP-4 (accession number: AF044310)
(forward; nt 182–201): 5′-ATGCCTCCCAAGTTTAAGCG-3′
(reverse; nt 587–607): 5′-TCAAGTACGGTATTTCATGAC-3′
VAMP-5 (accession number: NM_006634)
(forward; nt 58–78) 5′-ATGGCAGGAATAGAGTTGGAG-3′
(reverse; nt 389–399) 5′-GTCAGTTCCCAGGCCCTGAG-3′
Primers were designed using the Primer3 program (S. Roze and H.J.
Skaletsky, Whitehead Institute for Biomedical Research, MIT Center
for Genome Research, Boston, MA). The conditions for PCR ampliﬁca-
tion of cDNA were as follows: 1 cycle at 95 °C for 5 min as an initial
denaturation step; then, denaturation at 95 °C for 30 s, annealing for
30 s, and extension at 72 °C for 90 s (the number of cycles was 26 to 30,
depending on the linear range); followed by further incubation for
15 min at 72 °C (1 cycle). The annealing step was carried out at 60 °C
(caspase-1), 64 °C (caspase-3), 65 °C (VAMP-4, VAMP-5, β-actin), or
66 °C (A1). These experimental conditions were shown to be at the
linear phase of ampliﬁcation for each gene. After ampliﬁcation, an
aliquot of the PCR reaction was size fractionated onto a 2% agarose gel
in 1×TAE (40 mM Tris–acetate, 1 mM EDTA, pH 8.0) and checked for
the expected PCR products. The PCR products were cloned into the
pCR™ 2.1 vector using the TA cloning kit (Invitrogen, San Diego, CA),
and DNA sequencing was performed on both strands from 10
independent cDNA clones using a PE Applied Biosystems 377 DNA
sequencer (Perkin Elmer).
3. Results
3.1. Acquisition of phenotypic neutrophil hallmarks during DMSO
treatment of HL-60 cells
The human myeloid leukaemic HL-60 cell line can be differentiated
to cells showing many of the features of mature neutrophils following
treatment with 1.3% (v/v) DMSO. This differentiation process was
characterized by an increase in CD11b cell surface expression, loss of the
proliferative capacity, and acquisition of a variety of functional
characteristics of mature neutrophils, including generation of super-
oxide anion and secretion of lysosomal enzymes and (Fig. 1). Fully
neutrophil-differentiatedHL-60cells after treatmentwithDMSO for3–4
days acquiredmost of the functional features of mature neutrophils and
were ready to undergo spontaneous apoptosis (Fig. 1), like their
physiologic mature neutrophil counterparts (Santos-Beneit and Molli-
nedo, 2000). In addition, previous reports have shown that DMSO-
induced progressive morphologic neutrophil differentiation as well,
with the highest proportion ofmetamyelocyte and neutrophilmorphol-
ogy after 4-day DMSO treatment (Gahmberg et al., 1979). HL-60 cells
treated with DMSO for 24 h followed by exhaustive washing, and then
cultured in DMSO-free culture medium for additional 48 h, showed the
acquisition of the same neutrophil differentiation markers as those HL-
60 cells treatedwith DMSO for 72 h (data not shown), corroborating our
previous ﬁnding that 1-day DMSO treatment is sufﬁcient to commit HL-
60 cells to neutrophil differentiation (Mollinedo et al., 1993). Thus,
neutrophil differentiation of HL-60 cells following DMSO treatment
follows a series of stages that include: commitment (1-day treatment),
loss of proliferative capacity (1- and 2-day treatment), acquisition of
mature neutrophil functions (3- and 4-day treatment), and cell death by
apoptosis (5-day treatment).
Fig. 1. Functional analysis of HL-60 cell differentiation towards the neutrophil
lineage induced by 1.3% (v/v) DMSO. The following parameters were examined
every day during the 5-day DMSO treatment of HL-60 cells: CD11b cell surface
expression (A), cell proliferation (B), superoxide anion generation (C), secretion (D)
and apoptosis (E). Values in A–D referred to viable cells. Untreated control cells
were run in parallel. Data are shown as the means of three independent experi-
ments±S.D.
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proliferation and RNA processing during neutrophil differentiation of HL-
60 cells
We next analysed changes in gene expression patterns during the
whole neutrophil differentiation process by oligonucleotide micro-
arrays in order to couple gene expression proﬁles with the acquisition
of the above-mentioned neutrophil phenotypic hallmarks. We
searched for those genes that showed over a two-fold change in
their expression in at least one incubation time with DMSO compared
to untreated control cells. We have found that 962 out of the 12,625
gene probes were up- or down-regulated during neutrophil differ-
entiation of HL-60 cells (Supplementary Fig. S1). Most dramatic gene
expression changes occurred during the irreversible commitment
stage towards neutrophil differentiation (1-day DMSO treatment).
Major gene expression changes during DMSO-induced neutrophil
differentiation of HL-60 cells corresponded to genes involved in
transcription, cell cycle and proliferation, RNA processing, antigens
and receptors, superoxide anion generation, exocytosis, function and
signalling, cytokines, and apoptosis (Figs. 2 and 3).
Table 1 shows a list of genes whose expression change is ≥8-fold
during neutrophil differentiation of HL-60 cells. A more complete list
of genes, whose expression change is at least 2-fold in most of the
DMSO incubation times, is displayed in Supplementary Table S1.
A large number of transcription-related genes were up- and down-
regulated during neutrophil differentiation of HL-60 cells (Fig. 2, Table
1, and Supplementary Table S1). We found a relatively higher number
of up-regulated genes, including distinct inhibitor of DNA binding (Id)
genes, zinc ﬁnger proteins, jun B, and ring ﬁnger protein 13. The
inhibitor of DNA binding 1 gene (Id1) was dramatically up-regulated
(15-fold) during the ﬁrst day of DMSO treatment, and thereafter its
relative expression was highly diminished. Id2 was up-regulated
during the whole neutrophil differentiation process, its highest
expression occurring after a 3-day DMSO treatment (8-fold). A
number of zinc ﬁnger proteins resulted up-regulated during neutro-
phil differentiation, especially during the third day of DMSO
treatment, suggesting a role for these genes in the acquisition of the
mature neutrophil phenotype. Zinc ﬁnger protein 266 and zinc ﬁnger
protein 51 (BCL6), showed the highest up-regulation levels (40 and
20-fold, respectively at 3-day DMSO incubation) among all the
transcription-related genes analysed. In contrast, c-myc was strongly
down-regulated (13-fold) since the ﬁrst day of DMSO treatment, in
agreement with previous data (Watanabe et al., 1985). In our
microarray study, we detected a high increase in C/EBPδ (5-fold) and
C/EBPɛ (6-fold) after a 3-day DMSO treatment, supporting a role of
these transcription factors in the late events of neutrophil differentia-
tion, as previously reported (Lekstrom-Himes, 2001). Interestingly, we
found that RNA polymerase I was dramatically down-regulated by day
3 of DMSO treatment (11-fold). Because RNA polymerase I transcribes
18S and 28S genes, its down-regulation could explain the low
macromolecule biosynthetic capacity of neutrophils. Concerning the
expression of genes coding for transcription factors, we can
distinguish several time-dependent gene expression changes that
could be relevant for the whole neutrophil differentiation process
(Supplementary Table S1), namely: a) transcription factors whose
expression was altered in the commitment stage of HL-60 differentia-
tion towards neutrophils (1-day DMSO treatment), especially Id1 and
Id2 genes; b) those whose expression was altered in the late stages of
neutrophil maturation (3- and 4-day DMSO treatment), such as Id2,
zinc ﬁnger protein 266, BCL-6, C/EBPδ and C/EBPɛ; and c) those whose
expression was modiﬁed along the whole neutrophil differentiation
process, such as jun B and ring ﬁnger protein 13.
Most of the genes related to cell cycle, DNA replication and cell
proliferation were down-regulated during DMSO-induced neutrophil
differentiation of HL-60 cells, including cyclins, CDC kinases, and MCM
proteins (Fig. 2, Table 1, and Supplementary Table S1). In contrast, genes
Fig. 2. Functional classiﬁcation of genes modulated in DMSO-treated HL-60 cells. Genes were clustered hierarchically into three groups according to their respective cellular role: transcription, cell cycle and cell proliferation, and RNA
processing. For each gene, the ratio of mRNA levels in HL-60 cells at the indicated time after DMSO treatment (D1-4, days 1–4) to mRNA levels in untreated HL-60 cells is represented by color and ranges from highly increased (intense red) to












Fig. 3. Functional classiﬁcation of genes modulated in DMSO-treated HL-60 cells. Genes were clustered hierarchically into six groups according to their respective cellular role: function and signalling, apoptosis, antigens and receptors,













Table 1 Major gene expression changes in DMSO-induced differentiation of HL-60 cells and peripheral blood human neutrophils
Gene name Gene
symbol









1 d 2 d 3 d 4 d PMN
B-cell CLL/lymphoma 6 (zinc ﬁnger protein 51) BCL6 0.95 2.69 4.31 3.87 ↑↑↑ U00115 Transcription, inﬂammatory response
Inhibitor of DNA binding 1, dominant negative
helix-loop-helix protein
ID1 3.89 0.22 −0.67 0.12 ≈ X77956 Transcription
Inhibitor of DNA binding 2, dominant negative
helix-loop-helix protein
ID2 2.04 0.71 3.00 1.85 ↑ D13891 Transcription
Interferon consensus sequence binding protein 1 ICSBP1 −2.2 −2.1 −2.09 −3.19 ↓↓ M91196 Repression of transcription
RNA polymerase I subunit RPA40 −1.03 −1.87 −3.51 −1.44 ↓ AF008442 Transcription
v-myc myelocytomatosis viral oncogene homolog MYC −3.64 −3.38 −3.18 −3.88 ↓↓↓ V00568 Transcription
Zinc ﬁnger protein 266 ZNF266 0.91 2.48 5.31 1.99 ≈ AA868898 Transcription
BTG family, member 2 BTG2 2.34 3.15 3.49 3.30 ↑↑↑ U72649 Negative control of cell proliferation,
DNA repair
CDC45 cell division cycle 45-like CDC45L −1.16 −5.09 −2.64 −4.43 ↓↓ AJ223728 DNA replication
CDC6 cell division cycle 6 homolog CDC6 −0.69 −4.16 −5.05 −5.59 ↓ U77949 Cell cycle, DNA replication
Chromosome 6 open reading frame 32 (PL48) C6orf32 1.17 1.73 5.28 3.83 ↑↑↑ U49187 Cell cycle
Chromosome condensation 1-like CHC1L 1.41 2.24 1.90 3.42 ↑ AF060219 Chromosome condensation
Cyclin A1 CCNA1 −1.17 −1.00 −3.09 −2.13 ≈ U66838 Cell cycle
MCM4 minichromosome maintenance deﬁcient 4 MCM4 −0.43 −4.68 −2.25 −1.51 ↓↓↓ X74794 DNA replication, cell cycle
Polymerase (DNA directed), epsilon 2 POLE2 −0.81 −4.01 −3.69 −2.53 ↓↓ AF025840 DNA replication
Synaptonemal complex protein 2 SYCP2 −0.31 3.39 4.37 4.16 ↑ Y08982 Chromosome condensation
Uridine monophosphate synthetase UMPS −0.94 −2.13 −1.42 −3.00 ↓↓ J03626 Nucleic acid biosynthesis
Adenosine a2a receptor ADORA2A 1.57 2.24 3.92 3.53 ↑↑ S46950 Cellular defense response,
inﬂammatory response
CD11b antigen (integrin, alpha M) ITGAM 4.07 5.23 5.26 5.87 ↑↑↑ J03925 Cell adhesion
CD11c antigen (integrin, alpha X) ITGAX 1.72 3.77 2.48 3.49 ↑↑ Y00093 Cell adhesion
Complement component (3b/4b) receptor 1
(CD35)
CR1 −0.59 0.30 3.15 4.83 ↑↑↑ X14362 Complement activation
Complement component (3d/Epstein Barr virus)
receptor 2 (CD21)
CR2 −0.29 3.17 3.57 2.14 ↑↑↑ M26004 Complement activation
Fc fragment of IgG, low afﬁnity IIb, receptor for
(CD32)
FCGR2B 2.63 3.4 0.11 4.22 ↑↑ M31933 Immune response
Toll-like receptor 1 TLR1 2.58 1.45 3.44 3.26 ↑↑ AL050262 Immune response
Cytochrome b-245, beta polypeptide
(cytochrome b558) (gp91phox)
CYBB −1.63 −1.54 3.11 0.95 ≈ X04011 Superoxide anion generation
Neutrophil cytosolic factor 1 (47 kD) (p47phox) NCF1 1.63 1.40 2.33 3.00 ↑↑ M55067 Superoxide anion generation
Neutrophil cytosolic factor 2 (65 kD) (p67phox) NCF2 1.54 1.83 3.29 2.89 ↑↑↑ M32011 Superoxide anion generation
Vesicle-associated membrane protein 5 (myobrevin) VAMP5 1.68 3.06 2.39 2.73 ↑ AF054825 Vesicle transport
Aquaporin 9 AQP9 −0.13 −0.63 3.20 2.93 ↑↑↑ AB008775 Water transport, cell motility
Ninjurin 1 NINJ1 1.30 1.79 2.63 3.12 ↑ U91512 Cell adhesion
S100 calcium-binding protein a12 (calgranulin C) S100A12 1.23 1.52 6.11 5.61 ↑↑↑ D83664 Calcium binding,
inﬂammatory response
S100 calcium-binding protein A8 (calgranulin A)
(MRP-8)
S100A8 0.83 1.00 3.20 3.30 ↑↑ AI126134 Calcium binding,
inﬂammatory response
S100 calcium-binding protein A9 (calgranulin B)
(MRP-14)
S100A9 0.98 1.26 3.43 3.57 ↑↑ W72424 Calcium binding,
inﬂammatory response
Serine (or cysteine) proteinase inhibitor, clade A,
member 1
SERPINA1 0.46 1.44 3.17 3.19 ↑↑↑ X01683 Protease inhibition
TYRO protein tyrosine kinase binding protein
(DAP12)
TYROBP 1.93 2.68 3.72 4.03 ↑↑ W60864 Signal transduction
Vanin-2 VNN2 −0.35 0.41 6.43 5.92 ↑↑↑ D89974 Cell motility and adhesion
Chemokine (C–C-motif) ligand 2
(small inducible cytokine A2)
CCL2 0.01 −0.96 3.17 1.64 ↑↑ M26683 Cell–cell signalling,
signal transduction
Chemokine (C–C motif) ligand 3 CCL3 1.69 3.15 −0.72 1.71 ↑↑ D90144 Cell–cell signalling, chemotaxis,
inﬂammatory response
Interleukin 1, beta IL1B 3.35 3.97 3.39 3.37 ↑↑ X04500 Signal transduction
BCL2-related protein A1 BCL2A1 0.59 1.42 2.90 3.51 ↑↑↑ U27467 Anti-apoptosis
Heat shock 27 kD protein 1 HSPB1 −1.30 −1.38 −4.56 −1.93 ↓↓↓ Z23090 Anti-apoptosis
Heat shock 70 kD protein 6 (HSP70b) HSPA6 2.38 3.83 1.13 5.12 ↑↑↑ X51757 Anti-apoptosis
List of genes selected from Supplementary Fig. S1 and Supplementary Table S1 with a ≥8-fold change in expression during the neutrophil differentiation of HL-60 cells with DMSO.
The relative changes in gene expression values during DMSO-induced HL-60 cell differentiation compared to untreated control HL-60 cells were obtained using U95Av2 arrays and
MAS5.0 software and are shown as “signal log ratio” (SLR). The relative changes in gene expression values between peripheral blood human polymorphonuclear neutrophils (PMN)
and untreated HL-60 cells were obtained using U133A arrays and dChip1.3 software. ↑↑↑/↓↓↓, over 100-fold change; ↑↑/↓↓, fold change between 15–100-fold; ↑/↓ , fold change between
2–14-fold; ≈, no change.
22 F. Mollinedo et al. / Gene 419 (2008) 16–26negatively controlling cell proliferation (p19, p21CIP1, p27KIP1, BTG1 and
BTG2) were up-regulated (Table 1, and Supplementary Table S1). These
changes were generally detected since the ﬁrst two days of DMSO
treatment, coincident with the drastic loss of proliferative capacity of
DMSO-treated HL-60 cells. BUB and MAD genes, major components of
the mitotic checkpoint, and polo-like kinase, which plays an essentialrole for mitosis progression, were down-regulated since day 2 of DMSO
incubation. We also found that a gene known as PL48 behaved as a
marker for HL-60 neutrophils and was highly up-regulated during the
third (39-fold) and fourth (14-fold) day of DMSO treatment, when
neutrophil-like HL-60 cells were achieved. Expression of this gene has
been previously found to be dramatically increased by Northern blot in
Fig. 4. RT-PCR validation of the gene expression proﬁling data. The pattern of expression
of the indicated genes during DMSO-induced neutrophil differentiation of HL-60 cells
was assessed by semiquantitative RT-PCR. Representative gels of three performed are
shown.
23F. Mollinedo et al. / Gene 419 (2008) 16–26HL-60 cells treated with DMSO for 3 days, and has been suggested to
function as a tumor suppressor, arresting cells in G0 or G1 (Dakour et al.,
1997). Our data suggest that the loss of cell division capacity during
neutrophil differentiation is due to both down-regulation of mitotic
proteins and up-regulation of proliferation inhibitors.
Some genes involved in chromosome condensation, including
chromosome condensation 1-like and synaptonemal complex protein
2, were up-regulated during neutrophil differentiation of HL-60 cells
(Table 1). We also found that a wide number of genes involved in RNA
processing resulted down-regulated (Supplementary Table S1), that
could explain the low macromolecule biosynthesis capacity of mature
neutrophils (Jack and Fearon, 1988; Mollinedo et al., 1991b). Taken
together, these data show a general down-regulation of genes related
to cell cycle, proliferation and RNA processing, whereas there is a net
up-regulation in transcription-related genes (Fig. 2).
3.3. Changes in gene expression related to cell surface antigens and
receptors during neutrophil differentiation of HL-60 cells
The myeloid differentiation marker CD11b was dramatically
increased during neutrophil differentiation (59-fold after full neu-
trophil differentiation). Other cell surface proteins that were highly
up-regulated in fully differentiated HL-60 neutrophils include CD35
(28-fold), adenosine A2a receptor (15-fold), CD11c (11-fold), and
ICAM-3 (7-fold) (Fig. 3, Table 1, and Supplementary Table S1). Toll-like
receptor 1 (TLR1) and TLR2, key elements in pathogen recognition,
were also highly up-regulated (11- and 5-fold, respectively) during
HL-60 differentiation.
3.4. Changes in gene expression related to neutrophil functions,
signalling and cytokines during neutrophil differentiation of HL-60 cells
Expression of gp91phox, responsible for superoxide anion generation,
was highly increased (9-fold) at day 3 of DMSO treatment (Table 1),when
an efﬁcient respiratory burst is detected in fully differentiated HL-60
neutrophils (Fig.1). p47phox andp67phox, required for the stabilization and
full activation of the NADPH oxidase complex, were also up-regulated
(=˜8-fold) after 3- and 4-day of DMSO treatment (Fig. 3, Table 1).
The secretory capacity of HL-60 cells was greatly increased along
the differentiation process (Fig. 1), and several exocytosis-related
genes were up-regulated in parallel (Fig. 3, Supplementary Table S1). A
number of SNARE proteins have been shown to be involved in
neutrophil exocytosis (Martin-Martin et al., 2000; Mollinedo et al.,
2003; Mollinedo et al., 2006), and some SNARE proteins, including
SNAP-23, syntaxin 3A, VAMP-3, and VAMP-5 were up-regulated
during HL-60 neutrophil differentiation (Supplementary Table S1).
We also found signiﬁcant changes in the expression of genes coupled
to the acquisition of additional functions during neutrophil differentia-
tion, especially a predominant up-regulation during the third and fourth
day of DMSO treatment, when cells acquired functional features of
mature neutrophils (Fig. 1). This gene up-regulation pattern included
stannin (7-fold), a stress response gene that has been involved in
vascular endothelial damage (Horrevoets et al., 1999); ADAM8 (CD156)
(4-fold), involved in regulating leukocyte inﬁltration (Higuchi et al.,
2002; Gomez-Gaviro et al., 2007); aquaporin-9 (9-fold), a water
transporting protein involved in neutrophil motility (Loitto et al.,
2002); and vanin-2 (86-fold), a glycosylphosphatidyl inositol-anchored
protein involved in cell motility and adhesion (Suzuki et al., 1999)
(Table 1, and Supplementary Table S1).
We found that the expression of ornithine decarboxylase (ODC), a
molecule that is overexpressed in various cancers and is associated
with promoting tumor growth, resulted down-regulated (6-fold)
during neutrophil differentiation of HL-60 cells (Supplementary Table
S1). ODC is a physiological transcriptional target of c-Myc in
association with induction of cell proliferation and transformation
(Auvinen et al., 2003), and is the rate-controlling enzyme of sperminebiosynthesis, which together with other polyamines are essential for
cell survival and proliferation (Nitta et al., 2002).
The expression levels of calgranulins A (S100A8, MRP-8) (10-fold
increase), B (S100A9, MRP-14) (12-fold increase) and C (S100A12) (69-
fold increase) were dramatically up-regulated during the late stages of
neutrophil differentiation (Table 1). These proteins are members of
the S100 multigene family of calcium-binding proteins implicated in
the Ca2+-dependent regulation of a variety of intracellular activities,
including the dynamics of cytoskeletal rearrangement and structural
organization of membranes, intracellular Ca2+ homeostasis, inﬂam-
mation and protection from oxidative cell damage (Santamaria-Kisiel
et al., 2006). Inhibitors of neutral serine proteinases (serpins) (10-
fold), and the adhesion protein ninjurin (9-fold) were up-regulated in
fully neutrophil-like differentiated HL-60 cells (Table 1). DAP12, an
immunoreceptor tyrosine-based activationmotifs-bearing transmem-
brane adapter molecule expressed on the surface of NK and myeloid
cells and involved in both innate and adaptive immune responses
(Aoki et al., 2003), was also up-regulated (16-fold) during neutrophil
differentiation of HL-60 cells (Table 1). Genes involved in proteasome-
dependent protein degradation, such as proteasome subunits and
ubiquitin carrier protein, were down-regulated during HL-60 differ-
entiation (Supplementary Table S1). This could lead to a prolonged
protein half-life that could compensate for the poor macromolecule
biosynthesis capacity exerted by neutrophils.
Furthermore,we found that neutrophil differentiatingHL-60 cells up-
regulated theexpressionof a numberof cytokines and cytokine receptors
(Fig. 3, Table 1, and Supplementary Table S1), including small inducible
cytokineA2, chemokine (C-Cmotif) ligand3, chemokine (C-X-C) receptor
4, interleukins (IL) 1β, 8 and 18, IL-10 receptor, and transforming growth
factor beta receptor. These data support the ability of human neutrophils
to modulate immune responses ( Kobayashi, 2008).
3.5. Changes in gene expression related to apoptosis during neutrophil
differentiation of HL-60 cells
A remarkable hallmark of peripheral blood mature neutrophils is
their ability to undergo spontaneous apoptosis. In agreement with
our previous semiquantitative RT-PCR data (Santos-Beneit and
Mollinedo, 2000), we found a dramatic up-regulation of A1 (11-
fold), and a slight decrease in caspase-3 expression during
neutrophil differentiation of HL-60 cells (Fig. 3, Table 1, and
Supplementary Table S1). Chuang et al. (1998) also found by
Northern blot analysis a progressive A1 mRNA accumulation in HL-
24 F. Mollinedo et al. / Gene 419 (2008) 16–2660 cells during all-trans retinoic acid-driven neutrophilic differen-
tiation. Some pro-apoptotic genes were up-regulated during neu-
trophil differentiation, including genes potentiating apoptotic
signalling, such as BNIP3L, caspases 1 and 8, dual speciﬁcity
phosphatases, NF-kB inhibitor alpha, and serine/threonine kinases
(Fig. 3, Supplementary Table S1). Although some heat shock proteins
(HSPs) were down-regulated during neutrophil development,
including HSP10 and HSP27, a dramatic increase in heat shock 70
kD protein 6 (HSP70B) was detected (35-fold) after a 4-day DMSO
treatment (Table 1, and Supplementary Table S1). In this regard, the
Bcl-2-associated anthanogene 2 (BAG2) as well as the HSP70-
interacting protein HSPBP1 that function as negative regulators of
HSP70 chaperone activity (Nollen et al., 2000) were down-regulated
(Supplementary Table S1). Thus, the HSP70B up-regulation, together
with the down-regulation of two major negative regulators of its
chaperone activity, suggests a role for HSP70B in neutrophil survival.
3.6 . Validation of gene expression proﬁles detected with oligonucleotide
microarrays
We performed semiquantitative RT-PCR with a subset of differen-
tially expressed genes to conﬁrm the observed gene expression
patterns (Fig. 4). The results of this RT-PCR analysis showed a very
similar expression pattern to that of the microarray analysis, namely
caspase 1, A1, VAMP-4 and VAMP-5 were up-regulated during DMSO-
induced differentiation of HL-60 cells, whereas caspase 3 was slightly
down-regulated with a higher decrease at 2-day of DMSO incubationFig. 5. Major gene expression changes during DMSO-induced HL-60 cell differentiation into t
changes in gene expression coupled to the acquisition of neutrophil hallmarks in DMSO-in
change expression and their putative involvement in the granulocytic maturation process.
incubation are indicated. See text for further details.(cf. Figs. 3 and 4, and Supplementary Table S1). In addition, our
present microarray results ﬁt very well with previous Northern blot
analyses of certain genes during HL-60 cell differentiation towards
neutrophil lineage, such as the up-regulation of jun B (Mollinedo and
Naranjo, 1991; Mollinedo et al., 1991b) and SNAP-23 (Mollinedo and
Lazo, 1997) during the differentiation process.
3.7. Comparison of gene expression proﬁles between undifferentiated
HL-60 cells and peripheral blood human neutrophils
In order to compare the above data from the HL-60 cell line, used as
a neutrophil-like cell culture model, with the corresponding human
mature neutrophil counterparts, we next analysed and compared the
relative abundance ofmRNA transcripts in undifferentiatedHL-60 cells
and peripheral blood human neutrophils. We used U133A oligonu-
cleotide arrays, that contained 22,283 sets of oligonucleotide probes
representing about 18,000 full-length human sequences, and the
dChip1.3 software for analysis. A comparison of the gene expression
level in the U133A arrays showed 23% similarity between the gene
expression proﬁle of undifferentiated HL-60 cells and mature human
neutrophils. Interestingly, we found that practically all major gene
expression changes observed during DMSO-induced neutrophil
differentiation of HL-60 cells were correlated with a qualitatively
similar expression level in mature neutrophils (Table 1, and Supple-
mentary Table S1). This suggests that the regulation of, at least, part of
this set of selected genes could be enough and critical to differentiate
HL-60 cells into a neutrophil-like cell type, or that is to say, to turn ahe neutrophil lineage. This is a schematic diagram designed to portray some remarkable
duced HL-60 cell differentiation. Genes shown here were selected on both a high fold
Timings (1–4 days) for the functional and gene expression changes elicited by DMSO
25F. Mollinedo et al. / Gene 419 (2008) 16–26leukemic and proliferating cell into a non-proliferating and terminal
cell type that undergoes spontaneous apoptosis.
4. Discussion
The results reported here point out that a rather large number of
gene expression changes account for the acquisition of the neutrophil
phenotype during neutrophil differentiation of HL-60 cells. Our data
support the notion that neutrophil differentiation occurs via coordi-
nated, complex and successive changes in gene expression that are
modelling the ﬁnal functionally active neutrophil. Fig. 5 depicts a
schematic diagram of some of the major gene expression changes
herein detected during DMSO-induced neutrophil differentiation of
HL-60 cells coupled to the acquisition of neutrophil hallmarks. First,
differentiating HL-60 cells are arrested at G1 during the commitment
phase of HL-60 cell differentiation into the neutrophil lineage, which
correlates with a general down-regulation of genes related with cell
cycle and proliferation and remarkable changes in the expression of a
number of transcription factors. Differentiating HL-60 cells show also
defects in the RNA processing machinery that can be a regulatory
pathway tomodulate the amount and activity of certain gene products,
and might also explain the rather high expression of novel alternative
splicing-derived isoforms in neutrophils (Mollinedo and Lazo, 1997;
Martin-Martin et al., 1999; Eckhart et al., 2001; Herrero-Turrion et al.,
2006). Then, a dramatic change occurs in the expression of genes that
account for the functional traits of human mature neutrophils.
Lee et al. (2002) did not previously ﬁnd a common gene expression
proﬁle regulated by all-trans retinoic acid in NB4 and HL-60 cells, even
though this agent induced granulocytic differentiation in both cell types.
Thus, these data suggested that the molecular mechanism and genes
involved in retinoic acid-induced differentiation of leukemic cells may
be cell-type speciﬁc (Lee et al., 2002). Our present gene expression
proﬁle data of DMSO-induced differentiating HL-60 cells partially differ
from the gene expression pattern achieved by retinoic acid, but a num-
ber of genes, including Id2, BTG1, c-myc, interferon regulatory factor 1,
cyclin A1, CDK4, small inducible cytokine A2, calgranulin B, and ninjurin
1, are similarly regulated (Lee et al., 2002; Song et al., 2003). These data
suggest that different inducers of HL-60 cell differentiation towards
granulocytes can render differential gene expression changes. In ad-
dition, part of the differences between our present gene expression data
and those previously reported during HL-60 cell differentiation may lie
in the use of different microarrays. Earlier microarray studies with
retinoic acid-induced differentiation of HL-60 cells involved the use of
cDNA microarrays, namely 872 and 8353 cDNAs (Lee et al., 2002; Song
et al., 2003), whereas we have used here oligonucleotide microarrays,
analysing the expression of about 12,000 full-length genes through the
use of 12,625 sets of oligonucleotide probes.
HL-60 cells acquire the capacity to undergo spontaneous apoptosis
after full neutrophil differentiation (Fig. 1). However, we have found
that the highest up-regulation levels in apoptosis-related gene
expression were detected in anti-apoptotic genes, namely HSP70B
(35-fold) and A1 (11-fold) (Table 1). BTG2, identiﬁed as an anti-
proliferative gene (Sasajima et al., 2002) and involved in the survival
of differentiated cells (el-Ghissassi et al., 2002), was also highly up-
regulated (11-fold) (Table 1). Thus, BTG2, A1 and HSP70B could also
play a role in maintaining the short neutrophil lifespan. HSP70B up-
regulation together with the down-regulation of two negative
regulators of HSP70 chaperone activity, such as BAG2 and HSPBP1
(Supplementary Table S1), further supports a role for HSP70B in
preserving the lifespan of human neutrophils. On the other hand, IL-
1β acts in an autocrine manner to inhibit spontaneous neutrophil
apoptosis through its processing by caspase-1 (Watson et al., 1998).
We have found here that IL-1β and caspase-1 were up-regulated
during neutrophil development of HL-60 cells (Table 1, and Supple-
mentary Table S1). Thus, caspase-1-dependent activation of IL-1β
represents another additional mechanism bywhich neutrophils mightdelay its constitutive apoptosis. These data lead us to postulate that: a)
fully differentiated neutrophils acquire, during their development, a
gene expression pattern that drives cells into apoptosis by default; b)
neutrophil lifespan is regulated by the action of anti-apoptotic genes
that delay the apoptotic fate of mature neutrophils. In this regard,
inhibition of protein synthesis accelerates neutrophil cell death
(Sakamoto et al., 2003), suggesting that de novo synthesis of anti-
apoptotic proteins might regulate neutrophil lifespan. Thus, neutro-
phils are an excellent example of programmed cell death that acquire
their deadly genetic program during development.
The implications of the results reported here are 3-fold: a) to unravel
the gene expression changes that underlie the acquisition of neutrophil
hallmarks during granulocytic differentiation; b) to gain insight into the
transcriptional processes that regulate the short neutrophil lifespan; c)
to identify global gene expression changes that turn a proliferating
leukaemic cell into a non-dividing and terminal apoptosis-programmed
cell type. Deﬁnition of the gene expression patterns reported here
duringneutrophil differentiation ofHL-60cells couldbeof interest to get
further insight into the molecular basis of “differentiation therapy”,
which is part of standard treatment for patients with acute promyelo-
cytic leukaemia (Parmar and Tallman, 2003). Subsequent knockdown
and overexpression studies will be required to unravel the role of the
distinct genes, either individually or in combination, in neutrophil dif-
ferentiation. It could be envisaged, in analogy with structure-activity
relationship studies with home-made drugs, that the functionality and
phenotypic features of these leukocytes could be modulated by ap-
propriate modiﬁcation of the pattern or timing of gene expression.
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